These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 24183229)

  • 41. Autoreactivity to bullous pemphigoid 180: is this the link between subepidermal blistering diseases and oral lichen planus?
    Shipman AR; Cooper S; Wojnarowska F
    Clin Exp Dermatol; 2011 Apr; 36(3):267-9. PubMed ID: 20569254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Linear IGA dermatosis associated with ulcerative colitis.
    Fernández-Guarino M; Sáez EM; Gijón RC; García BP; Olasolo PJ
    Eur J Dermatol; 2006; 16(6):692-3. PubMed ID: 17229615
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug induced linear IgA disease with unusual features: Koebner phenomenon, local insulin sensitivity and annular blister of the nipples.
    Rashid Dar N; Raza N
    Acta Dermatovenerol Croat; 2008; 16(4):215-7. PubMed ID: 19111146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of animal skin substrates for indirect immunofluorescence diagnosis of subepidermal autoimmune bullous diseases.
    Kanitakis J; Cozzani E; Peyron E; Bourchany D; Claudy A
    Arch Dermatol; 1994 Dec; 130(12):1558. PubMed ID: 7986134
    [No Abstract]   [Full Text] [Related]  

  • 45. Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme.
    Armstrong AW; Fazeli A; Yeh SW; Mackool BT; Liu V
    J Cutan Pathol; 2004 May; 31(5):393-7. PubMed ID: 15059226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Immunolabeling methods in cutaneous histopathology. Principles and practical applications].
    Kanitakis J; Thivolet J
    Ann Pathol; 1987; 7(2):79-97. PubMed ID: 3304316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histologic assessment of perilesional skin in vesiculobullous diseases: giving its due.
    Tirumalae R; Yeliur IK
    Am J Dermatopathol; 2012 Jun; 34(4):455-7. PubMed ID: 21959124
    [No Abstract]   [Full Text] [Related]  

  • 48. The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease.
    Tjokrowidjaja A; Daniel BS; Frew JW; Sebaratnam DF; Hanna AM; Chee S; Dermawan A; Wang CQ; Lim C; Venugopal SS; Rhodes LM; Welsh B; Nijsten T; Murrell DF
    Br J Dermatol; 2013 Nov; 169(5):1000-6. PubMed ID: 24102329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoimmune bullous diseases associations.
    Ljubojevic S; Lipozenčić J
    Clin Dermatol; 2012; 30(1):17-33. PubMed ID: 22137223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vesiculo-ulcerative diseases and periodontal practice.
    Rees TD
    J Periodontol; 1995 Aug; 66(8):747-8. PubMed ID: 7473019
    [No Abstract]   [Full Text] [Related]  

  • 51. [Immunohistology of bullous autoimmune skin diseases].
    Ledoux M; Achten G; Shahabpour M
    Acta Stomatol Belg; 1991 Apr; 88(1):31-8. PubMed ID: 1950839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bizarre, polycyclic, circinate, and floral-patterned reversible depigmentation in a patient with chronic bullous disease of childhood.
    Solanki LS; Srivastava N; Chand S; Singh S
    Int J Dermatol; 2008 Jul; 47(7):704-6. PubMed ID: 18613878
    [No Abstract]   [Full Text] [Related]  

  • 53. Linear immunoglobulin A bullous dermatosis.
    Fortuna G; Marinkovich MP
    Clin Dermatol; 2012; 30(1):38-50. PubMed ID: 22137225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug-induced linear IgA bullous dermatosis.
    Navi D; Michael DJ; Fazel N
    Dermatol Online J; 2006 Sep; 12(5):12. PubMed ID: 16962027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An acquired bullous dermatosis due to an autoimmune reaction against uncein.
    Horiguchi Y; Ueda M; Shimizu H; Tanaka T; Matsuyoshi N; Utani A; Ikai K; Nishikawa T; Imamura S
    Br J Dermatol; 1996 May; 134(5):934-8. PubMed ID: 8736340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transient intra-epidermal bullous dermatosis.
    Bukhari I
    Eur J Dermatol; 2005; 15(4):288-90. PubMed ID: 16048761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokines in autoimmune bullous skin diseases. Epiphenomena or contribution to pathogenesis?
    Ludwig RJ; Schmidt E
    G Ital Dermatol Venereol; 2009 Aug; 144(4):339-49. PubMed ID: 19755940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutaneous signs update.
    Gellin GA
    Skinmed; 2003; 2(6):337; author reply 337. PubMed ID: 14673243
    [No Abstract]   [Full Text] [Related]  

  • 59. Quality of Life in Greek Patients with Autoimmune Bullous Diseases Assessed with ABQOL and TABQOL Indexes.
    Patsatsi A; Kokolios M; Kyriakou A; Lamprou F; Stylianidou D; Tsapas A; Goulis DG; Murrell DF; Sotiriadis D
    Acta Derm Venereol; 2017 Oct; 97(9):1145-1147. PubMed ID: 28660281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Auto-immune bullous dermatosis].
    Bonnetblanc JM
    Ann Dermatol Venereol; 2005 Feb; 132(2):188-9. PubMed ID: 15798576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.